The Need for a Low-Expense Universally Acceptable rhTSH Protocol

TO THE EDITOR: Thyroid cancer is a rare malignancy ([1][1]). Most cases are of well-differentiated epithelial papillary and follicular carcinomas. As most thyroid cancer has a low mortality rate and a moderately high recurrence rate, lifelong monitoring is required ([2][2],[3][3]). The 2 most